A multicenter, randomized, non-comparative, phase II study of nivolumab ± ipilimumab for patients with metastatic sarcoma (Alliance A091401): Expansion cohorts and correlative analyses

Authors

Nathan D Seligson, University of Florida
James L Chen, The Ohio State University
Austin C Goodrich, Mayo Clinic
Brian A Van Tine, Washington University School of Medicine in St. Louis
Jordan D Campbell, Mayo Clinic
Allison L Richards, Memorial Sloan Kettering Cancer Center
Cristina R Antonescu, Weill Cornell Medical College
David A Liebner, The Ohio State University
Mohammed M Milhem, University of Iowa
Howard Streicher, National Cancer Institute
William D Tap, Weill Cornell Medical College
Gary K Schwartz, Case Western Reserve University
Suzanne George, Dana Farber Cancer Institute
Sandra P D'Angelo, Weill Cornell Medical College

Journal

Journal for ImmunoTherapy of Cancer

Publication Date

9-28-2024

Volume

12

Issue

9

First Page

e009472

Document Type

Open Access Publication

DOI

10.1136/jitc-2024-009472

Rights and Permissions

Seligson ND, Chen JL, Goodrich AC, Van Tine BA, Campbell JD, Richards AL, Antonescu CR, Liebner DA, Milhem MM, Streicher H, Tap WD, Schwartz GK, George S, D'Angelo SP. A multicenter, randomized, non-comparative, phase II study of nivolumab ± ipilimumab for patients with metastatic sarcoma (Alliance A091401): expansion cohorts and correlative analyses. J Immunother Cancer. 2024 Sep 28;12(9):e009472. doi: 10.1136/jitc-2024-009472.© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.

Recommended Citation

Seligson, Nathan D; Chen, James L; Goodrich, Austin C; Van Tine, Brian A; Campbell, Jordan D; Richards, Allison L; Antonescu, Cristina R; Liebner, David A; Milhem, Mohammed M; Streicher, Howard; Tap, William D; Schwartz, Gary K; George, Suzanne; and D'Angelo, Sandra P, "A multicenter, randomized, non-comparative, phase II study of nivolumab ± ipilimumab for patients with metastatic sarcoma (Alliance A091401): Expansion cohorts and correlative analyses." Journal for ImmunoTherapy of Cancer. 12, 9. e009472 (2024).
https://digitalcommons.wustl.edu/oa_4/4376

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.